| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7b57a4cbebeaae92a21cb9e418e43cbb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6849
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2854
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2851
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 |
| filingDate |
2016-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f81936c445765afd4f5ee338fcd515c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b0b0785864c7d0df0b988e782a98563
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20c57745dbc8e3686375da411e8e477d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d796b09dca613cfd23a954a50b53aca7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6104d0b5a3921fdfc8f7719ceb52970b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba7bc303093e42a2d130aeffc7d59b63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88a985cd6165f5e51cc5bcaa7b212a68 |
| publicationDate |
2017-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017041001-A2 |
| titleOfInvention |
Insulin immunoglobulin fusion proteins |
| abstract |
Disclosed herein are immunoglobulin fusion proteins comprising an insulin therapeutic peptide and an immunoglobulin region that targets the insulin therapeutic peptide to the liver of an individual in need thereof. Further disclosed herein are compositions comprising the immunoglobulin fusion proteins and methods for using the immunoglobulin fusion proteins for the treatment or prevention of a disease or condition in a subject, for example, diabetes and diabetes related conditions. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021022149-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10501546-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114174348-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11421033-B2 |
| priorityDate |
2015-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |